Product Information
FT TRIPLE ANTIBIOTIC-PAIN OINT is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1261 per GM under NDC 70677121901. Its NADAC has been published 113 times since Aug 7, 2024.
FT TRIPLE ANTIBIOTIC-PAIN OINT
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine HydrochlorideStrength
500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
Manufacturer
Strategic Sourcing Services LLCNDC
70677121901
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
1/29/2024
Pharmacological Classes
Price Statistics
The NADAC for FT TRIPLE ANTIBIOTIC-PAIN OINT has been published 113 times since Aug 7, 2024, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1261 per GM |
|---|---|
| All-time high | $0.1315 (Oct 16, 2024) |
| All-time low | $0.1246 (Apr 23, 2025) |
| 52-week high | $0.1293 |
| 52-week low | $0.1261 |
| Median price | $0.1277 |
| Average price | $0.1276 |
| Largest weekly change | -4.7% (Oct 23, 2024) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT TRIPLE ANTIBIOTIC-PAIN OINT?
The current National Average Drug Acquisition Cost (NADAC) for FT TRIPLE ANTIBIOTIC-PAIN OINT, manufactured by Strategic Sourcing Services LLC, is $0.1261 per GM (NDC 70677121901), effective Sep 30, 2026.
How has the price of FT TRIPLE ANTIBIOTIC-PAIN OINT changed over time?
Over the history we have for it, the NADAC for FT TRIPLE ANTIBIOTIC-PAIN OINT has declined 3.2%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for FT TRIPLE ANTIBIOTIC-PAIN OINT?
Since Aug 7, 2024, the NADAC for FT TRIPLE ANTIBIOTIC-PAIN OINT has ranged from a low of $0.1246 (Apr 23, 2025) to a high of $0.1315 (Oct 16, 2024), with a median of $0.1277 per GM.
Are there cheaper alternatives to FT TRIPLE ANTIBIOTIC-PAIN OINT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM TRIPLE ANTIBIOTIC PLUS OINT, is $0.1246 per GM — about 1% below FT TRIPLE ANTIBIOTIC-PAIN OINT.
Who manufactures FT TRIPLE ANTIBIOTIC-PAIN OINT?
FT TRIPLE ANTIBIOTIC-PAIN OINT (NDC 70677121901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.